Hepatology
813 articles · 19 journals
Journals in this subcategory (19)
- Annals of Hepatology · Elsevier (90)
- Journal of Hepatology · Elsevier (80)
- Journal of Hepato-Biliary-Pancreatic Sciences · Wiley (74)
- HPB · Elsevier (72)
- Gastroenterology · Elsevier (64)
- Gastroenterología y Hepatología · Elsevier (63)
- Journal of Clinical and Experimental Hepatology · Elsevier (61)
- Clinics in Liver Disease · Elsevier (48)
- Cellular and Molecular Gastroenterology and Hepatology · Elsevier (45)
- Journal of Liver Transplantation · Elsevier (44)
- Journal of Gastroenterology and Hepatology (Australia) · Wiley (41)
- The Lancet Gastroenterology & Hepatology · Elsevier (37)
- Liver International · Wiley (34)
- Portal Hypertension and Cirrhosis · Wiley (28)
- Liver Research · Elsevier (19)
- Journal of Viral Hepatitis · Wiley (13)
- Current Hepatology Reports · Springer Nature (0)
- Egyptian Liver Journal · Springer Nature (0)
- Hepatology International · Springer Nature (0)
- Observership to Japan 2026 (Dr. Vutha Meas): What I Experienced in Japan and What I Will Practice in My Country
- Feasibility and Impact of Traction Band‐Assisted Cannulation for Difficult Biliary Cannulation in Patients With Periampullary Diverticulum: A Propensity Score‐Matched Analysis
- Reply to the Letter to the Editor Regarding “Stump Ischemia Is a Possible Risk Factor for Late‐Onset Pancreatic Fistula After Distal Pancreatectomy”
- Observership to Japan 2026 (Dr Lokesh Agarwal): What I Experienced in Japan and What I Will Practice in My Country
-
Advances in Viral Markers for Predicting Functional Cure of Chronic Hepatitis B
ABSTRACT First‐line antiviral therapies for chronic hepatitis B include nucleos(t)ide analogues and pegylated interferon‐α. However, neither therapy can completely eliminate hepatocellular covalently closed circular DNA, making complete...
- Comment on “Stump Ischemia Is a Possible Risk Factor for Late‐Onset Pancreatic Fistula After Distal Pancreatectomy”
-
Diagnosis of Portal Hypertension: Advancing Towards Non‐Invasive Solutions
ABSTRACT Portal hypertension (PH) is a clinical syndrome characterized by elevated portal venous pressure and represents a major complication of chronic liver disease. It serves as the underlying cause of several life‐threatening...
- Preclinical Efficacy and Safety Evaluation of a Novel Controlled‐Expansion ePTFE‐Covered TIPS Stent in a Swine Model
-
Recovering the Recovering Liver Graft
The shortage of liver grafts from deceased donors is universal. A deceased‐donor whole liver from an otherwise healthy brain‐dead donor is ideal for transplantation. This situation however is very uncommon since deceased donors often...
- “Pitfalls in assessing platelet activation status in patients with liver disease: authors’ reply”
- Quantitative bias analysis of unmeasured confounding refines interpretation of longitudinal associations between cardiometabolic risk factors and liver stiffness in MASLD
- Reply to: Correspondence on “Longitudinal changes in cardiometabolic risk factors are associated with changes in liver stiffness in adults with MASLD”
- Beyond alkaline phosphatase: Can anti–integrin αvβ6 autoantibodies serve as biomarkers in primary sclerosing cholangitis trials?
- Quantifying the delivered dose of bulevirtide in clinical trials and real-world use: A dose recovery study
- Corrigendum to: ‘Generation of hepatobiliary organoids from human induced pluripotent stem cells’ [J Hepatol (2019) 70 (6):1145–1158]
- What are the subsegments of the right hemiliver and when are they surgically relevant? A systematic review
- Infectious complications after liver resection in patients with prior biliary-enteric anastomosis: a multicenter retrospective cohort study
- Association of metabolic dysfunction-associated steatotic liver disease with colorectal cancer incidence and surgical outcomes
- Microbiota–Taurine Pathway Links Dietary Fiber to Mucosal Healing
- Coaching Language to Improve Endoscopy Training Quality (CLIEnT): A Randomized Controlled Trial
- Mevalonate Biosynthesis is a Metabolic Vulnerability of Gemcitabine-Resistant Pancreatic Cancer
- Irritable Bowel Syndrome and Suicide Risk
- What Men Live By: Family Ties as a Bridge to Persistent Nonparticipants in Colorectal Cancer Screening
- The role of inpatient palliative care consultation in end-stage liver disease: Too little, too late?
- Patient-Centred Sleep Outcome Definitions in Primary Biliary Cholangitis: A Call for Patient Engagement in Future Research
- International expert Delphi consensus on the management of metabolic dysfunction- and alcohol-associated liver disease (MetALD)
- Interpreting large esophageal varices as a predictor of hepatocellular carcinoma
- First-day clinical phenotyping in acute-on-chronic liver failure: a 24-hour landmark analysis with preliminary external reproducibility
- Systemic therapy for HCC: Doublets, triplets and beyond
- Systemic therapy of biliary tract cancer: The road to personalised strategies